#EPSAAC23 | Lina Savšek, MD, PhD, has held a presentation about the therapeutic advances for #Multiple #Sclerosis. 💊In the presentation the full therapeutic range of MS has been covered, from disease modifying medications to the challenge of treating progressive MS. #Symposium

#EPSAAC23 | Ms. Evelyn Donohoe, Policy Officer European Health Management Association has delivered a presentation on "Addressing challenges in access to treatments for neurodegenerative diseases". 🤔In the presentation we explored how barriers to therapeutic management access could be overcome. #Symposium

#EPSAAC23 | Following the second round of presentations a panel discussion is held on the topic of "Paving the way towards better #efficacy, #safety and #accesibility of the treatment for neurodegenerative diseases". The discussion is open to #student questions. #Symposium

#EPSAAC23 I Feeling very inspired by the talk of Darija Kuruc Poje from @EAHPtweet about the role of #hospital pharmacists in the management of neurodegenerative diseases

#EPSAAC23 | On the second day of Symposium we tackle the importance of the role of a #hospitalpharmacist in the management of neurodegenerative diseases 🧠 Thank you Dr. Darija Kuruc Poje, Vice President EAHP for providing such an insteresting insight @EAHPtweet EPSA

#EPSAAC23 | Monika Firer, MPharm has presented about the role of public pharmacists in the treatment of Neurodegenerative Diseases. 💊During the presentation we learned about different methods and tools that we can utilize as pharmacists, supporting patient treatment. #Symposium

What about the role of community pharmacists? Monika Firer, a Pharmacist at Public Pharmacies of Celje, is sharing her experience on: ▫️Advising proper use of medicines ▫️Recommending more patient-friendy formulations ▫️Providing cognitive services #EPSAAC23

#EPSAAC23 | 🗣️ Andreja Špeh is highlighting that It is important to recognize the role of caregivers in : ▫️Providing emotional support and assisting with daily living. ▫️Offering adequate support and recourses to both individuals with dementia and their caregivers.

#EPSAAC23 I 🗣 Andreja Špeh is teaching us about psychosocial interventions in dementia during the 2️⃣nd day of the EPSA AC23 Symposium EPSA

#EPSAAC23 | M. Sc. in Psychology, Andreja Špeh has presented to us about psychosocial interventions that can be utilised for people with dementia. 🧠 During the presentation we explored the different types of such interventions and their benefits for the patients. #Symposium

#EPSAAC23 | Thank you to ECCRT for sponsoring this EPSA Annual Congress and presenting us with their STAR programme. An exciting opportunity to be considered! 🙌📚

#EPSAAC23 I Discussing the importance of #interprofessional #collaboration👥 for patient’s welfare in the pharmaceutical curricula📚 🗣 Lilian M. Azzopardi, President of #EAFP EPSA

BPSS 🇱🇻 | Yesterday I had the opportunity to present EPSA at the Baltic Pharmaceuticals Students Seminar. Very glad this was a moment of exchange were students asked questions and shared experiences 💪 #pharmacystudents #advocacy #representation #sharingexperiences

#BPIEurope BPI started with a very interesting keynote delivered by Felix Oehme on how platform approaches can be used for efficient manufacturing of a diverse biologics pipeline and how the industrialization platform will deliver future live-savings drugs. Bayer | Pharmaceuticals

#RAPSEuroConvergence | Starting the event with a plenary session on leveraging joint clinical data📄 🤝Thank you Regulatory Affairs Professionals Society, especially Kim A. Young, for inviting EPSA to the event and the warm welcome!

#RAPSEuroConvergence is off to a great start after an excellent opening plenary on leveraging joint clinical data 📊

#RAPSEuroconvergence I Beginning the 2️⃣nd day of the event with discussing whether revision of the EU 🇪🇺 general #pharmaceuticals #legislation📝 will deliver a future-proof medicines 💊 #regulatory system for Europe EPSA Regulatory Affairs Professionals Society

#RAPSEuroconvergence I “AI/machine⚙️ learning based-medical software can improve the accuracy in diagnosis and treatment of diseases🦠, which improves the health care of patients. However, it also brings some challenges in its regulatory compliance.” EPSA Regulatory Affairs Professionals Society

#RAPSEuroconvergence I Putting EMA’a 🇪🇺 PRIME scheme under review by discussing its findings and future directions↗️ 🗣Kevin Cunningham, PhD (EMA) EPSA Regulatory Affairs Professionals Society